Safe and Effective Use of Low-Dose Clozapine for Tardive Dyskinesia in a Patient with Schizophrenia and Comorbid Epilepsy: A Case Report

Safe and Effective Use of Low-Dose Clozapine for Tardive Dyskinesia in a Patient with Schizophrenia and Comorbid Epilepsy: A Case Report

Bibliographic Details
Main Author:	Mahmut Selçuk
Format:	Article
Language:	English
Published:	AVES 2023-06-01
Series:	Psychiatry and Clinical Psychopharmacology
Online Access:	https://psychiatry-psychopharmacology.com/en/safe-and-effective-use-of-low-dose-clozapine-for-tardive-dyskinesia-in-a-patient-with-schizophrenia-and-comorbid-epilepsy-a-case-report-133208

Similar Items

Genome wide study of tardive dyskinesia in schizophrenia
by: Lim, Keane, et al.
Published: (2022)

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
by: Olga Yu. Fedorenko, et al.
Published: (2022-06-01)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia
by: Naser tabibi, et al.
Published: (2010-11-01)

Tardive Dyskinesia and Treatment Approaches
by: Mehmet Emin Demirkol, et al.
Published: (2018-06-01)

Improvement of Tardive Dyskinesias with Olanzapine
by: S. Echater, et al.
Published: (2023-01-01)

Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01)

Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia
by: E. E. Vaiman, et al.
Published: (2019-12-01)

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024-01-01)

Tetrabenazine for treating neuroleptic-induced tardive dyskinesia: A case report of a patient with chronic schizophrenia
by: Pao- Yuan Ching, et al.
Published: (2021-01-01)

Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia
by: E. E. Vaiman, et al.
Published: (2020-12-01)

Facial mask masking tardive dyskinesia
by: I. Ganhao
Published: (2021-04-01)

Pathophysiology, prognosis and treatment of tardive dyskinesia
by: Hiroyoshi Takeuchi, et al.
Published: (2022-10-01)

Clinical Diagnosis and Treatment of Tardive Dyskinesia
by: WANG Xixi, et al.
Published: (2022-07-01)

A case of tardive dyskinesia with paliperidone palmitate
by: Philip Kumar Boyanapally, et al.
Published: (2015-01-01)

Severity of Tardive Dyskinesia and Negative Symptoms are Associated with Poor Quality of Life in Schizophrenia Patients
by: Othman, Zahiruddin, et al.
Published: (2013)

CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
by: Ye. G. Kornetova, et al.
Published: (2015-02-01)

Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
by: Rupniak, N, et al.
Published: (1990)

Treatment of Tardive Dyskinesia with High Dose Vitamin B6 Associated with Depression
by: Marjorie McCoy, et al.
Published: (2022-07-01)

“Clozapine & Valbenazine for Treatment of Tardive Cervical Dystonia: A Case Report”
by: Chandani Lewis, et al.
Published: (2023-07-01)

Improvement of Tardive Dyskinesia during Mindfulness Meditation
by: Maria Angela Santoro, et al.
Published: (2021-08-01)

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia
by: Adrianna Szczakowska, et al.
Published: (2023-02-01)

The usage of clozapine in a patient with schizophrenia and epilepsy: A case report
by: M. Karnickas, et al.
Published: (2021-04-01)

Altered DNA methylation of CYP2E1 gene in schizophrenia patients with tardive dyskinesia
by: Ping Zhang, et al.
Published: (2022-12-01)

Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation
by: Rodrigo A. Gutierrez, BS, et al.
Published: (2024-03-01)

Putative role of immune reactions in the mechanism of tardive dyskinesia
by: Anton J.M. Loonen
Published: (2023-11-01)

Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
by: E. E. Vayman, et al.
Published: (2020-01-01)

Tardive dyskinesia: understanding current challenges in diagnosis and treatment
by: David Taylor, et al.
Published: (2023-01-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Improvement of tardive dyskinesia in a depressive patient treated with fluvoxamine
by: G. Dzhupanov
Published: (2023-03-01)

Treatment of tardive dyskinesias with vitamin E: A case series
by: B. Senol, et al.
Published: (2023-03-01)

Illustration of the dramatic and dynamic efficacy of chronic GPi-DBS therapy in a patient with tardive dyskinesia/dystonia
by: Halil Onder, et al.
Published: (2024-01-01)

An investigation on the relationship between risk factors and severity of tardive dyskinesia
by: Y Kalafi, et al.
Published: (1993-12-01)

Digital functionally generated path technique in a tardive dyskinesia patient
by: A/Prof Du Hyeong Lee, et al.
Published: (2023-09-01)

Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States
by: Rakesh Jain, et al.
Published: (2023-11-01)

Treatment of tardive dyskinesia: a review and update for dermatologists managing delusions of parasitosis
by: Christian Cheng, et al.
Published: (2022-04-01)

Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report
by: Xiaoling Guo, et al.
Published: (2023-10-01)

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
by: Shintaro Sakai, et al.
Published: (2021-09-01)

Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
by: Jiang Q, et al.
Published: (2023-11-01)

Tardive dyskinesia: apropos of a case. This is a case related to drug side effects, whose uniqueness lies in the time of onset of symptoms, Tardive dyskinesia is a drug-induced hyperkinetic movement disorder.
by: R. F. Díaz
Published: (2023-03-01)

Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
by: Claassen Daniel O. MD, et al.
Published: (2023-10-01)